Schmidt & Clark, LLP | A National Law Firm

Norpramin (desipramine hydrochloride) Lawsuit


|


On December 2, 2009 the U.S. Food & Drug Administration (FDA) in association with Sanofi-Aventis notified healthcare professionals that there were substantial changes made to the Warnings and Overdosage sections in the labeling for the popular antidepressant Norpramin (generic: desipramine hydrochloride).

The manufacturer has issued the following warning:

Extreme caution should be used when this drug is given to patients who have a family history of sudden death, cardiac dysrhythmias, and cardiac conduction disturbances; and that seizures precede cardiac dysrhythmias and death in some patients.

Additional Resources:

Do I Have a Norpramin Lawsuit?

The Product Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in drug side effect lawsuits. We are currently evaluating potential Norpramin and desipramine side effect claims in all 50 states.

If you or somebody you know have used Norpramin or desipramine and since suffered from an adverse event, you should contact us immediately. You may be entitled to compensation by filing a lawsuit and we can help. Please use the form below to contact our Product Liability Litigation Group or call toll free 24 hours a day at (866) 588-0600.

Attention Attorneys:  Schmidt & Clark considers a referral from another law firm to be one of the greatest compliments. Our law firm has built a reputation for success and accepts a number of case referrals on a regular basis. We do not publish prior verdicts or settlements on our website. If you would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.